pISSN 1226-6051
eISSN 2508-786X

Table. 5.

Table. 5.

Prescription patterns of inhaled medications by number of drug category combinations

2015 2016 2017 2018 CAGR (%)




No. of Prescription (%) No. of Prescription (%) No. of Prescription (%) No. of Prescription (%)
Inhaled medication prescription per category
Total no. of 1 category prescription 6,653(42.2) 6,347 (37.5) 5,135(30.6) 4,242 (25.6) -13.9
ICS 1,246(7.9) 1,447 (8.5) 1,275 (7.6) 1,208 (7.3) -1.0
LAMA 4,446(28.2) 4,262 (25.2) 3,407(20.3) 2,735 (16.5) -15.0
LABA 961(6.1) 638 (3.8) 453 (2.7) 299 (1.8) -32.2
Total no. of 2 category prescription 4,930 (31.2) 6,485 (38.3) 7,596 (45.2) 8,392 (50.6) 19.4
ICS+LABA Combination 3,932 (24.9) 3,980 (23.5) 4,009 (23.9) 3,934 (23.7) 0.0
ICS/LABA 3,723(23.6) 3,769 (22.3) 3,797 (22.6) 3,808 (22.9) 0.8
ICS+LABA 44(0.3) 19 (0.1) 14 (0.1) -(0.0) -100.0
ICS+ICS/LABA 165 (1.0) 192 (1.1) 198 (1.2) 126(0.8) -8.6
ICS+LAMA 155 (1.0) 149 (0.9) 89 (0.5) 70 (0.4) -23.3
LAMA/LABA Combination 843 (5.3) 2,356 (13.9) 3,498 (20.8) 4,388 (26.4) 73.3
LAMA/LABA fixed dose combination 321 (2.0) 1,973 (11.6) 3,383 (20.1) 4,331 (26.1) 138.1
LAMA+LABA concomitant prescription 522(3.3) 383 (2.3) 115 (0.7) 57 (0.3) -52.2
Others 6,653(42.2) 6,347 (37.5) 5,135(30.6) 4,242 (25.6)
Total no. of 3 category prescription 4,198 (26.6) 4,107 (24.2) 4,060 (24.2) 3,966 (23.9) -1.9
ICS/LABA+LAMA 3,959 (25.1) 3,703 (21.9) 3,618 (21.5) 3,323 (20.0) -5.7
ICS+LAMA/LABA 29 (0.2) 151 (0.9) 190 (1.1) 276 (1.7) 111.9
ICS+LAMA+LABA 28 (0.2) 15 (0.1) 3 (0.0) 15 (0.1) -18.8
ICS/LABA+ICS+LAMA/LABA - (0.0) 6 (0.0) 6 (0.0) 6 (0.0)
ICS/LABA+LAMA+ICS 108(0.7) 114 (0.7) 101 (0.6) 114 (0.7) 1.8
ICS/LABA+LABA+LAMA 40 (0.3) 10 (0.1) 7(0.0) 10 (0.1) -37.0
ICS/LABA+LAMA/LABA 34 (0.2) 108 (0.6) 135 (0.8) 222 (1.3) 86.9
Total (Sum) 15,781 16,939 16,791 16,600 1.7

No. of Category prescription including various combination prescription. Except Short-acting Bronchodilator. ICS: Inhaled Corticosteroid LAMA: Long-Acting Muscarinic Antagonist, LABA: Long acting β2 agonist, CAGR: compound annual growth rate by 4years, ICS/LABA: 1 Medication prescription (ICS/LABA fixed dose Combination), ICS+LABA; 2 medication prescription (ICS medication +LABA medication)

Korean J Clin Pharm 2022;32:155-65 https://doi.org/10.24304/kjcp.2022.32.3.155
© 2022 Korean J Clin Pharm